docCorporate Overview - MiraVista Diagnostics
download 
Report Transcription
Experience the ADVANTAGE www.MiraVistaLabs.com 866.647.2847 Qualifications + Strengths Features + Benefits Licenses + Certifications Clinical Expertise Serious Fungal Infection Diagnostics Aspergillus Testing Beta D Glucan Testing Blastomyces DermatitidisTesting Coccidioides Testing Cryptococcus Testing Histoplasma Capsulatum Testing Anti-Fungal Therapeutic Drug Monitoring Medical Mycology Fungal Infection Diagnostics for Human Health Antigen Testing + Detection Antibody Testing + Detection Anti-Fungal Therapeutic Drug Monitoring Medical Diagnostics + Testing Medical Diagnostics + Testing Medical Diagnostics + Testing Veterinary Mycology Fungal Infection Diagnostics for Animal Health Antigen Testing + Detection Antibody Testing + Detection Anti-Fungal Therapeutic Drug Monitoring Veterinary Diagnostics + Testing Veterinary Diagnostics + Testing Veterinary Diagnostics + Testing Let us earn your trust + your business. Send us your fungal testing to experience the ADVANTAGE. www.MiraVistaLabs.com 866.647.2847
Similar documents
Global Veterinary Diagnostics Market Size, Share, Development, Growth and Demand Forecast to 2020
The global veterinary diagnostics market is growing significantly due rising requirement for combat antimicrobial-resistant bacteria, increasing awareness of animal health in emerging economies, and growing investment in developing economies in the industry. Increasing number of new and technologically advanced products in veterinary diagnostics market is creating sufficient opportunity for the veterinary diagnostics market to grow at a substantial rate in the forecasted period. In addition, massive unexplored market in veterinary diagnostics industry of developing economies are creating ample opportunities for the veterinary diagnostics market to grow at a considerable rate in the coming years.
Hematological Disorder Drugs And Diagnostics Market
global Hematological Disorder Drugs And Diagnostics Market for hematological disorder is expected to grow at the CAGR 5.6% during 2015-2022.
